1. Please check and comment entries here.
Table of Contents

    Topic review

    Fibroblast Memory in Development, Homeostasis and Disease

    Subjects: Cell Biology
    View times: 5
    Submitted by:


    Fibroblasts are the major cell population in the connective tissue of most organs, where they are essential for their structural integrity. They are best known for their role in remodelling the extracellular matrix, however more recently they have been recognised as a functionally highly diverse cell population that constantly responds and adapts to their environment. Biological memory is the process of a sustained altered cellular state and functions in response to a transient or persistent environmental stimulus. While it is well established that fibroblasts retain a memory of their anatomical location, how other environmental stimuli influence fibroblast behaviour and function is less clear. The ability of fibroblasts to respond and memorise different environmental stimuli is essential for tissue development and homeostasis and may become dysregulated in chronic disease conditions such as fibrosis and cancer. 

    1. Positional Memory

    Anatomical location is an important organising principle for a diverse number of cell types in multicellular organisms [1]. Fibroblasts are the major structural cells in almost every organ which differentiate into tissue specific subpopulations during morphogenesis. The demands on connective tissue (e.g., physical and mechanical challenges, environmental stress and ageing, permeability and elasticity, cellular and molecular composition, etc.) are highly heterogenous across body sites and within organs such as the skin, joints, lung or heart. Although we don’t yet fully understand the extent of anatomical variation of connective tissue functions, maybe the positional identity of the fibroblast helps in establishing and maintaining specialist features during development, homeostasis and repair.
    In the hallmark study by Chang et al., comparison of foetal and adult fibroblasts from 10 different anatomical locations has revealed distinct gene expression patterns between different organs but also within a tissue along the developmental body axes reflecting their embryonic origins [2]. Approximately 8% of all genes transcribed in fibroblasts are differentially expressed in a site-specific manner and are involved in regulation of ECM synthesis, lipid metabolism, and cell signalling pathways such as TGF-β, Wnt and GPCR controlling proliferation, cell migration, and differentiation. For example, while both foetal lung and skin fibroblasts express high levels of type IV collagen, a central component of the basement membrane, only dermal fibroblasts synthesise type I and V collagen, which is essential for the tensile strength of adult skin dermis. Similarly, differentiation factors such as FOXF1 that are essential for the lung branching morphogenesis are restricted to foetal lung fibroblasts. Intriguingly, the site-specific transcriptional differences can be maintained long-term in vitro and are not influenced by different culture conditions (asynchronous cell growth or in serum-free media conditions), establishing the concept of positional memory in fibroblasts. A subsequent, largescale study of primary fibroblasts utilising adult human tissue samples extracted across 43 unique body sites discovered differences that related to the three anatomical axes: anterior-posterior, proximal-distal, and dermal versus non-dermal [3]. Analysis of the 317 genes that were enriched in fibroblast samples across these different sites revealed several HOX genes, which are known master regulators of positional identity during body morphogenesis. Indeed, clustering of fibroblasts based on 51 key homeodomain transcription factors was able to map their respective anatomical location. While expression of the HOXB gene is limited to the trunk and non-dermal samples, HOXD4 and HOXD8 are exclusively expressed in the trunk and proximal leg samples and HOXA13 is only present in adult fibroblasts extracted from distal sites. Functionally, continuous HOX gene activity appears to be vital in adult cells for enabling persistent expression of genes relevant to their positional identity within the tissue. For example, HOXA13 activity in adult fibroblasts maintains the expression of WNT5A and epidermal keratin 9, which is essential for their distal-specific transcriptional program [4], highlighting their importance for tissue development and homeostasis. As in dermal or lung fibroblasts, positional HOX gene signatures are sufficient to discriminate synovial fibroblasts in the joints from different body sites. A transcriptomic screening of synovial fibroblasts from different anatomical sites and patients with different clinical pathologies revealed that fibroblasts clustered according to anatomical location rather than disease type or progression [5]. The synovial fibroblast samples could be assigned to the original joint location by clustering the transcripts from HOX loci, emphasising the importance of HOX gene activity for their positional identity. Here, HOXA and HOXD gene transcripts define positional identity of distal synovial fibroblasts of the hand joints, whereas shoulder-derived synovial fibroblasts express a combination of HOXAHOXB and HOXD transcripts; HOXC locus transcripts also distinguish knee from upper extremity synovial fibroblasts. In addition, a large-scale RNA-seq analysis of primary human fibroblasts from healthy cadavers confirmed that fibroblast heterogeneity clusters among different anatomical locations as opposed to the donors, pointing to a highly conserved fibroblast tissue diversity [6].

    2. Mechanical Memory

    In their role as structural cells of tissues, fibroblasts must sense the mechanical environment which in turn instructs their cell behaviour and fate during development, homeostasis and disease. Some of these changes are able to persist for longer time periods after removal of the mechanical stimulus, establishing the concept of mechanical memory [7]. Synthesis of ECM components are coupled to mechanical sensing to maintain homeostasis and establish the tissue architecture. In the skin, for example, the dermal maturation is governed by a coordinated switch in fibroblast behaviour from highly proliferative in embryonic development to quiescence, and high ECM deposition/remodelling postnatally that is maintained by the surrounding ECM network [8]. Upon organ injury, disruption of the mechanical tissue integrity results in enhanced mechanical stress, differentiation to myofibroblasts and increased ECM synthesis/remodelling. The increased expression of α-Smooth muscle actin (αSMA) observed in many activated (myo)fibroblasts is both a reflection of the increased environmental mechanical stress (mechano-sensing) as well as the functional requirement for a contractile phenotype vital for restoring mechanical homeostasis (tissue contraction). In addition, myofibroblasts deposit an ECM rich in profibrotic mediators, including extradomain-A (ED-A) splice variant of fibronectin, periostin, tenascin-C, and latent transforming growth factor-β (TGF-β) binding protein-1 (LTBP-1), all of which facilitate the repair process [9]. Fibroblasts are able to release covalently bound latent TGF-β in the ECM, a key chemical stimulator of myofibroblast conversion [10], in a mechanical process that is enhanced in stiff ECM environment [11]. Similarly, in activated myofibroblasts Twist1 was shown to directly upregulate Prr1 expression which increases tenascin-C synthesis and reenforces Twist1 expression in a positive feedback loop [12]. Thus, myofibroblasts are prone to enter a positive mechanical feedback loop of cell contraction induced matrix stiffening and profibrotic ECM deposition/remodelling that reinforces and potentially memorises their activated state. While this multi-layered feedback loop guarantees a fast and efficient tissue repair, a persistent induction can evolve to pathological tissue fibrosis, a key characteristic of many inflammatory disorders and cancer [13].
    Different mechanical cues and ECM organisations can promote distinct cellular responses. Cyclic stretching of primary human lung fibroblasts for examples inhibits myofibroblast differentiation by reduced paracrine expression of TGF-β [14]. Culturing fibroblasts on stiff and soft culture conditions have been shown to promote distinct transcriptional signatures that are able to prime cells long-term. Fibroblast expanded in stiff microenvironments maintain a profibrotic phenotype over several weeks when switched to a soft substrate. Conversely, soft substrate culture upregulates MMP-1, MMP-3 and MMP-13 production and reduces expression of fibrosis-associated genes (such as α-SMA, Col type-1, and CTGF) in skin or cardiac fibroblasts, restraining their activation when plated on a stiff culture substrate [15][16]. After myocardial infarction, the mechanical properties of the heart change regionally and over time, inducing distinct phenotypes in cardiac fibroblasts that can be recapitulated in vitro [17]. While paracrine signalling from stretched cardiomyocytes promotes fibroblast proliferation, direct fibroblast stretching induced ECM synthesis and progressive matrix stiffening lead to an upregulation of αSMA expression and a switch from type I to type III collagen production. This example emphasizes how different mechanical cues within an organ can induce distinct profibrotic phenotypes of activated fibroblasts, which need to be considered for the development of future, fibroblast-targeted therapies.
    Although myocardial infarction induced fibrosis is generally thought of as irreversible, some degree of resolution can be observed after acute injury and its subsequent repair process. In addition to apoptosis, lineage tracing experiments indicate that some myofibroblasts in the heart can differentiate into a less activated and non-proliferative state [18]. This new stable cell state, referred to as matrifibrocyte, expresses an ECM gene signature rich in bone-cartilage markers such as chondroadherin and cartilage oligomeric matrix protein (Comp), reminiscent of tendon, and is anticipated to promote a mature scar, respond differently to mechanical cues and support the heart against further damages [19]. Currently, it is unclear if matrifibrocytes are also present in scar tissue from other organs. By combining ATAC-seq and RNA-seq analysis, a recent study indicates that the martrifibrocyte phenotype is maintained by changes in chromatin accessibility and gene expression [20] and harnessing this cell plasticity may be therapeutically valuable.
    Within a cell these different mechanical cues are received and processed via mechanosensitive proteins at the cell membrane-cytoskeletal cortex interface. PIEZO1/1, TRPC3/6 and TRPV4 are all examples of proteins involved in the mechano-sensing that act in concert with the cytoskeleton and cell-cell and cell-ECM adhesion receptors at the cell surface (e.g., integrins and cadherins) [21]. These mechanical forces can either result in direct downstream transcriptional regulation via cytoplasmatic/nuclear localisation of YAP/TAZ, NFκB and SRF/MAL or directly affect the chromatin organisation in the nucleus [22][23][24][25]. Notably, chromatin displays rheological properties through its ability to contort under mechanical load, resulting in direct transcriptional changes [23]. Short-term application of mechanical stress of 17.5 Pa was shown to double transcription of DHFR, a housekeeping gene necessary for the formation of thymidine through the reduction of dihydrofolate into tetrahydrofolate [26]. In contrast, long-term stimulation resulted in heterochromatin formation via the ATP-dependent condensation pathway leading to a global reduction in gene transcription [27]. It is conceivable that both direct nuclear adaptations to mechanical stimuli as well as activity of other mechano-sensing pathways (such as YAP/TAZ) modulate fibroblast gene transcription, behaviour and fate as shown for multipotent stem cells [28][29]. In line, Roy et al., revealed that culturing of fibroblasts on micropatterned substrates that laterally confined their growth was sufficient to induce their reprogramming to a more stem cell-like state [30]. Intriguingly, this approach enabled rejuvenation of aged fibroblasts upon redifferentiation in a 3D collagen matrix, indicating a potential therapeutic application [31]. Similarly, inhibition of focal adhesion kinase (FAK), a well-established transducer of mechanical forces, reduced YAP/TAZ-ERK induced scar formation by promoting AKT-EGR1 signalling and thus a more regenerative wound repair [32].

    3. Inflammatory Memory

    Fibroblasts are increasingly being recognised as essential cells for the immune system [33]. They are equipped with pattern recognition receptors (PRRs) and can secrete a large range of inflammatory mediators such as cytokines and chemokines. During development, immune cells progressively populate various organs, and it is conceivable that there is an adaptive signalling crosstalk between infiltrating immune cells and various fibroblast populations in the tissue. For the adaptive immune system, immune memory is essential to mount an effective immune response to specific inflammatory stimuli, and aberrant inflammatory memory can lead to multiple chronic inflammatory diseases. Also, cells of the innate immune system exhibit ‘trained immunity’, an epigenetic memory of pathogen encounters priming the innate immune system for repeat exposure. Thus, it is not surprising that fibroblasts, as mediators of inflammation, are capable of memorising inflammatory insults as well. Indeed, fibroblasts are emerging as key players in several chronic inflammatory conditions, such as rheumatoid arthritis [34], Lyme arthritis [35], scleroderma [36], and atopic dermatitis [37]. Therefore, it is crucial to understand how fibroblasts respond to inflammation and how fibroblast immune memory can prolong inflammatory stress following the initial exposure.
    During tissue damage-induced inflammation, ECM remodelling can release damage associated molecular patterns (DAMPs), such as fibronectin fragments, from unfolding or enzymatic digestion [38], while wound infiltrating pathogens release pathogen associated molecular patterns (PAMPs) such as bacterial lipopolysaccharides (LPS). Fibroblasts can sense DAMPs and PAMPs through a repertoire of toll-like receptors (TLRs) with substantial heterogeneity in sensitivity [39] and subsequently release cytokines, remodel ECM and attract immune cells. Tolerance to repeated TLR signalling is important for preventing damage from an excessive inflammatory response. LPS is an agonist of TLR4, which is expressed on the surface of multiple tissue fibroblasts, however the ability to memorize TLR4 stimulation varies among different fibroblast populations. Repeated LPS stimulation causes loss of activating histone marks in anti-viral genes in dermal fibroblasts and fibroblast-like synoviocytes (FLS), but not in gingival and neonatal foreskin fibroblasts [40].
    In addition to TLRs, fibroblasts can sense inflammatory signals through cytokine receptors, which can lead to long-term changes in fibroblast behaviour. For instance, prolonged TNFα signalling causes chromatin remodelling in FLS, accompanied by an increase in nuclear localisation of NFκB [41][42][43]. This is not only observed in FLS, but also in fibroblasts from chronically inflamed gum and skin. Mechanistically, a three-day exposure of fibroblasts to TNFα results in an increased response to interferon stimulation for several days after TNFα removal, which was characterised by decreased histone abundance and increased histone acetylation and STAT-1 signalling [41]. Thus, in fibroblasts, a memory of the TNFα stimulation is maintained through a combination of chromatin remodelling and sustained increased expression of pro-inflammatory cell signalling pathways.
    Besides TNFα, several interleukins (IL) have been implicated in the inflammatory memory of fibroblasts. IL-8 is important for attracting immune cells and promoting phagocytosis and angiogenesis. In normal wounds, IL-8 levels are low, but burn wounds often have slow healing areas with elevated IL-8 expression. Exposing dermal fibroblasts to elevated levels of IL-8 in vitro was shown to inhibit fibroblast long-term contraction [43], and it is hypothesised that this memory effect could alter ECM deposition/remodelling and influence epithelial cell migration during wound repair [44]. Viral infections induce secretion of IL-13, which can prime fibroblasts for conversion to tertiary lymphoid structures [45]. The IL-13 response in fibroblasts is modulated by miRNA-135b, which is downregulated through DNA hypermethylation in systemic sclerosis [46]. In addition, miRNAs that are associated with inflammatory memory in immune cells [47] have also been shown to regulate various fibroblast functions [48][49][50]; whether they play a role in fibroblast inflammatory memory is unclear.
    The inflammatory fibroblast phenotype is also influenced by the metabolic state. Increased expression of hexokinase 2 (HK2), a key enzyme of glucose metabolism, results in an invasive and migratory cellular state in rheumatoid arthritis associated FLS [51]. Knockdown of HK2 in mice was shown to reduce arthritis severity, bone, and cartilage damage, suggesting a direct link between immune response and metabolic deregulation in fibroblasts [51]. Pericytes are a specialised fibroblast subpopulation that reside on blood vessels at the interface between the blood and connective tissue and are involved in controlling immune cell migration through expression of cytokines and adhesion molecules. It has been shown that retinal pericytes retain a memory of high glucose and respond with a sustained inflammatory phenotype, even when returned to normal glucose conditions [52]. Currently, the underlying mechanism remains unclear; however, epigenetic profiling of vascular smooth muscle cells from diabetic mice suggests that it could be mediated by removal of repressive histone modifications at proinflammatory promoters [53]. Similarly, whether pericytes from other tissues (e.g., skin) are capable of maintaining an inflammatory memory of high glucose exposure warrants further investigation.

    4. Metabolic Memory

    Cellular metabolic state is an important regulator of fibroblast behaviour in development, homeostasis, wound healing, and disease. The metabolic programme (the balance in a cell between metabolic pathways such as glycolysis, oxidative phosphorylation, and lipolysis) regulates energy and metabolite intensive activities such as ECM production and reorganisation, myofibroblast contraction, migration, and proliferation [54][55]. While most fibroblasts are proliferative during development, in homeostasis adult fibroblasts generally exist in a quiescent state with a distinct metabolic programme [8], which is actively maintained by repressing proliferation and the transition into senescence or terminal differentiation [56][57]. Notably, quiescent fibroblasts remain highly metabolically active and increase expression of ECM proteins such as collagen I and III, which is partly controlled by miRNAs including miRNA-29 [58][59].
    In disease the balance of oxidative phosphorylation, aerobic glycolysis and fatty acid oxidation can become dysregulated, as observed in skin fibrosis with an increase in glycolysis and decrease in fatty acid oxidation [54]. Fibroblasts can sense intracellular and extracellular metabolic changes in their microenvironment through metabolic sensors such as C-terminal binding protein 1 (CtBP1) and respond with an altered metabolic programme and cell behaviour [60]. Intriguingly, these responses can persist even after the metabolic stimulus has subsided, suggesting that fibroblasts are capable of memorising specific changes in metabolism. The oncogenic metabolic phenotype of cancer associated fibroblasts (CAFs), for example, was recently shown to be maintained through a reduction of DNA and histone methylation caused by a nicotinamide N-methyltransferase (NNMT) induced depletion of S-adenosyl methionine (SAM), a universal methyl donor [61].
    In the lungs, arteries and heart, changes in blood pressure and the availability of oxygen to fibroblasts can signal tissue damage or disease. Hypoxia-induced pulmonary hypertension, for example, causes adventitial fibroblasts to switch to glycolytic metabolism with corresponding increase in NADH. The high NADH levels are sensed by fibroblasts though CtBP1, which promotes a pro-inflammatory and proliferative cellular state. When these adventitial fibroblasts are returned to normoxia culture conditions, they maintain a persistent glycolytic programme characterised by increased proliferation and inflammatory signalling which can be reversed by pharmacologically reducing NADH or silencing CtBP1 [60]. In addition, the persistent hypoxia-induced profibrotic changes in adventitial fibroblasts have been recently linked to specific alterations in mitochondrial metabolism in pulmonary hypertension conditions leading to a metabolic pyruvate to lactate shift and increased mitochondrial superoxide production [62]. Also cardiac fibroblasts are able to maintain a metabolic memory of hypoxia, promoting a persistent profibrotic environment with increased proliferation, fibroblast activation and excessive collagen and cytokine secretion [63][64]. These pro-fibrotic changes are associated with global DNA hypermethylation and increased expression of the DNA methyltransferase (DNMT) enzymes DNMT1 and DNMT3B, which is controlled by hypoxia-inducible factor (HIF)-1α. DNMTs depletion or inhibition significantly reduces collagen deposition, αSMA expression and response to profibrotic cytokines in cardiac fibroblasts [64]. Beside promoting the expression of fibrogenic cytokines, like TGF-β1 and CTGF, HIF-1α, it was shown to increase the expression of pyruvate dehydrogenase kinase (PDK) in profibrotic cardiac fibroblasts. PDK inhibition reverses the mitochondrial-metabolic phenotype and decreases fibroblast proliferation and collagen production in vitro [63]. Mechanistically, epigenetic suppression of the mitochondrial gene superoxide dismutase 2 (SOD2) by DNA methylation causes decreased mitochondrial hydrogen peroxide signalling and a metabolic shift with increased uncoupled glycolysis, which is maintained by the DNMT-HIF-1α-PDK feedback loop and global DNA hypermethylation. Thus, metabolic memory of hypoxia in fibroblasts is mediated by a combination of sustained transcriptional repressor activities (CtBP1), epigenetic changes (DNA methylation) and altered mitochondrial metabolism.
    Fibroblasts have also been shown to sense and memorise increased exposure to specific metabolites such as glucose. Diabetes is a disease with increased risk of hyperglycaemia and is associated with metabolic dysregulation such as reduced perfusion and oxygenation, and increased catabolism through hormone signalling [65]. Analysis of dermal fibroblasts from diabetic patients shows altered gene expression when exposed to high glucose conditions in vitro, compared to fibroblasts from non-diabetic donors [66]. In fibroblasts, hyperglycaemia results in a pattern of DNA methylation surrounding genes associated with wound repair, angiogenesis, and ECM assembly, which persists for multiple passages in vitro in normoglycemic conditions. It has been suggested that this metabolic priming of dermal fibroblasts may contribute to the impaired wound healing observed in diabetic patients [67]. Indeed, cultured fibroblasts from type 2 diabetes patients show decreased sensitivity to TNFα stimulation compared to healthy donors, which is probably driven by epigenetic modifications [68]. Whether these changes in fibroblast behaviour and hyperglycaemic memory are limited to dermal fibroblasts, or extend to fibroblasts in other organs, warrants further investigation.
    The metabolic state of fibroblasts can be influenced by several paracrine and autocrine signals from neighbouring cells within the microenvironment. A hallmark of cancer is a dysregulated metabolism in which cancer cells undergo metabolic reprogramming to aerobic glycolysis, providing metabolites for cell division. This metabolic switch is known as the “Warburg effect” and has also been observed in activated T cells and fibroblasts [69][70][71]. Moreover, cancer cells can induce aerobic glycolysis in neighbouring fibroblasts to provide an environment rich in metabolites needed for anabolism, in a process termed the “Reverse Warburg effect”. In breast cancer autocrine and paracrine TGF-β signalling have been shown to induce downregulation of the membrane protein caveolin-1 (Cav-1) in CAFs. Loss of Cav-1 causes CAF metabolic reprogramming to aerobic glycolysis, mitochondrial dysfunction and increased autophagy/mitophagy, which propagates to neighbouring CAFs and promotes the anabolic growth of adjacent cancer cells [72]. Notably, in rheumatoid arthritis, T helper cells have been shown to reprogramme fibroblasts to a glycolytic phenotype [73], suggesting that fibroblast metabolic reprogramming is a common feature in cancer and inflammatory diseases. Similarly, this phenotype can be further induced and maintained by autocrine TGF-β signalling and is able to spread to adjacent fibroblasts through paracrine signalling [72]. An autocrine TGF-β signalling loop, as a form of memory, is also observed in kidney fibrosis, in which myofibroblast-induced tension causes the release of TGF-β1, prolonging a contractile and glycolytic phenotype [74].

    This entry is adapted from 10.3390/cells10112840


    1. Chang, H.Y. Anatomic Demarcation of Cells: Genes to Patterns. Science 2009, 326, 1206–1207.
    2. Chang, H.Y.; Chi, J.-T.J.-T.; Dudoit, S.; Bondre, C.; van de Rijn, M.; Botstein, D.; Brown, P.O. Diversity, Topographic Differentiation, and Positional Memory in Human Fibroblasts. Proc. Natl. Acad. Sci. USA 2002, 99, 12877–12882.
    3. Rinn, J.L.; Bondre, C.; Gladstone, H.B.; Brown, P.O.; Chang, H.Y. Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs. PLoS Genet. 2006, 2, e119.
    4. Rinn, J.L.; Wang, J.K.; Allen, N.; Brugmann, S.A.; Mikels, A.J.; Liu, H.; Ridky, T.W.; Stadler, H.S.; Nusse, R.; Helms, J.A.; et al. A Dermal HOX Transcriptional Program Regulates Site-Specific Epidermal Fate. Genes Dev. 2008, 22, 303–307.
    5. Frank-Bertoncelj, M.; Trenkmann, M.; Klein, K.; Karouzakis, E.; Rehrauer, H.; Bratus, A.; Kolling, C.; Armaka, M.; Filer, A.; Michel, B.A.; et al. Epigenetically-Driven Anatomical Diversity of Synovial Fibroblasts Guides Joint-Specific Fibroblast Functions. Nat. Commun. 2017, 8, 14852.
    6. Foote, A.G.; Wang, Z.; Kendziorski, C.; Thibeault, S.L. Tissue Specific Human Fibroblast Differential Expression Based on RNAsequencing Analysis. BMC Genom. 2019, 20, 308.
    7. Balestrini, J.L.; Chaudhry, S.; Sarrazy, V.; Koehler, A.; Hinz, B. The Mechanical Memory of Lung Myofibroblasts. Integr. Biol. 2012, 4, 410.
    8. Rognoni, E.; Pisco, A.O.; Hiratsuka, T.; Sipilä, K.H.; Belmonte, J.M.; Mobasseri, S.A.; Philippeos, C.; Dilão, R.; Watt, F.M. Fibroblast State Switching Orchestrates Dermal Maturation and Wound Healing. Mol. Syst. Biol. 2018, 14, 1–20.
    9. Schuster, R.; Rockel, J.S.; Kapoor, M.; Hinz, B. The Inflammatory Speech of Fibroblasts. Immunol. Rev. 2021, 302, 126–146.
    10. Hinz, B.; Phan, S.H.; Thannickal, V.J.; Galli, A.; Bochaton-Piallat, M.-L.; Gabbiani, G. The Myofibroblast. Am. J. Pathol. 2007, 170, 1807–1816.
    11. Wipff, P.-J.; Rifkin, D.B.; Meister, J.-J.; Hinz, B. Myofibroblast Contraction Activates Latent TGF-Β1 from the Extracellular Matrix. J. Cell Biol. 2007, 179, 1311–1323.
    12. Yeo, S.-Y.; Lee, K.-W.; Shin, D.; An, S.; Cho, K.-H.; Kim, S.-H. A Positive Feedback Loop Bi-Stably Activates Fibroblasts. Nat. Commun. 2018, 9, 3016.
    13. Wynn, T.A. Cellular and Molecular Mechanisms of Fibrosis. J. Pathol. 2008, 214, 199–210.
    14. Blaauboer, M.E.; Smit, T.H.; Hanemaaijer, R.; Stoop, R.; Everts, V. Cyclic Mechanical Stretch Reduces Myofibroblast Differentiation of Primary Lung Fibroblasts. Biochem. Biophys. Res. Commun. 2011, 404, 23–27.
    15. Achterberg, V.F.; Buscemi, L.; Diekmann, H.; Smith-Clerc, J.; Schwengler, H.; Meister, J.-J.; Wenck, H.; Gallinat, S.; Hinz, B. The Nano-Scale Mechanical Properties of the Extracellular Matrix Regulate Dermal Fibroblast Function. J. Investig. Dermatol. 2014, 134, 1862–1872.
    16. Childers, R.C.; Lucchesi, P.A.; Gooch, K.J. Decreased Substrate Stiffness Promotes a Hypofibrotic Phenotype in Cardiac Fibroblasts. Int. J. Mol. Sci. 2021, 22, 6231.
    17. Herum, K.M.; Choppe, J.; Kumar, A.; Engler, A.J.; McCulloch, A.D. Mechanical Regulation of Cardiac Fibroblast Profibrotic Phenotypes. Mol. Biol. Cell 2017, 28, 1871–1882.
    18. Kanisicak, O.; Khalil, H.; Ivey, M.J.; Karch, J.; Maliken, B.D.; Correll, R.N.; Brody, M.J.; Lin, S.-C.J.; Aronow, B.J.; Tallquist, M.D.; et al. Genetic Lineage Tracing Defines Myofibroblast Origin and Function in the Injured Heart. Nat. Commun. 2016, 7, 12260.
    19. Fu, X.; Khalil, H.; Kanisicak, O.; Boyer, J.G.; Vagnozzi, R.J.; Maliken, B.D.; Sargent, M.A.; Prasad, V.; Valiente-Alandi, I.; Blaxall, B.C.; et al. Specialized Fibroblast Differentiated States Underlie Scar Formation in the Infarcted Mouse Heart. J. Clin. Investig. 2018, 128, 2127–2143.
    20. Li, C.; Sun, J.; Liu, Q.; Dodlapati, S.; Ming, H.; Wang, L.; Li, Y.; Li, R.; Jiang, Z.; Francis, J.; et al. The Landscape of Accessible Chromatin in Quiescent Cardiac Fibroblasts and Cardiac Fibroblasts Activated after Myocardial Infarction. Epigenetics 2021. Online ahead of print.
    21. Tschumperlin, D.J.; Ligresti, G.; Hilscher, M.B.; Shah, V.H. Mechanosensing and Fibrosis. J. Clin. Investig. 2018, 128, 74–84.
    22. Janmey, P.A.; Wells, R.G.; Assoian, R.K.; McCulloch, C.A. From Tissue Mechanics to Transcription Factors. Differentiation 2013, 86, 112–120.
    23. Miroshnikova, Y.A.; Nava, M.M.; Wickström, S.A. Emerging Roles of Mechanical Forces in Chromatin Regulation. J. Cell Sci. 2017, 130, 2243–2250.
    24. Liu, F.; Lagares, D.; Choi, K.M.; Stopfer, L.; Marinković, A.; Vrbanac, V.; Probst, C.K.; Hiemer, S.E.; Sisson, T.H.; Horowitz, J.C.; et al. Mechanosignaling through YAP and TAZ Drives Fibroblast Activation and Fibrosis. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2015, 308, L344–L357.
    25. Elsharkawy, A.M.; Mann, D.A. Nuclear Factor-ΚB and the Hepatic Inflammation-Fibrosis-Cancer Axis. Hepatology 2007, 46, 590–597.
    26. Tajik, A.; Zhang, Y.; Wei, F.; Sun, J.; Jia, Q.; Zhou, W.; Singh, R.; Khanna, N.; Belmont, A.S.; Wang, N. Transcription Upregulation via Force-Induced Direct Stretching of Chromatin. Nat. Mater. 2016, 15, 1287–1296.
    27. Heo, S.-J.; Han, W.M.; Szczesny, S.E.; Cosgrove, B.D.; Elliott, D.M.; Lee, D.A.; Duncan, R.L.; Mauck, R.L. Mechanically Induced Chromatin Condensation Requires Cellular Contractility in Mesenchymal Stem Cells. Biophys. J. 2016, 111, 864–874.
    28. Le, H.Q.; Ghatak, S.; Yeung, C.-Y.C.; Tellkamp, F.; Günschmann, C.; Dieterich, C.; Yeroslaviz, A.; Habermann, B.; Pombo, A.; Niessen, C.M.; et al. Mechanical Regulation of Transcription Controls Polycomb-Mediated Gene Silencing during Lineage Commitment. Nat. Cell Biol. 2016, 18, 864–875.
    29. Yang, C.; Tibbitt, M.W.; Basta, L.; Anseth, K.S. Mechanical Memory and Dosing Influence Stem Cell Fate. Nat. Mater. 2014, 13, 645–652.
    30. Roy, B.; Venkatachalapathy, S.; Ratna, P.; Wang, Y.; Jokhun, D.S.; Nagarajan, M.; Shivashankar, G.v. Laterally Confined Growth of Cells Induces Nuclear Reprogramming in the Absence of Exogenous Biochemical Factors. Proc. Natl. Acad. Sci. USA 2018, 115, E4741–E4750.
    31. Roy, B.; Yuan, L.; Lee, Y.; Bharti, A.; Mitra, A.; Shivashankar, G.V. Fibroblast Rejuvenation by Mechanical Reprogramming and Redifferentiation. Proc. Natl. Acad. Sci. USA 2020, 117, 10131–10141.
    32. Wong, V.W.; Rustad, K.C.; Akaishi, S.; Sorkin, M.; Glotzbach, J.P.; Januszyk, M.; Nelson, E.R.; Levi, K.; Paterno, J.; Vial, I.N.; et al. Focal Adhesion Kinase Links Mechanical Force to Skin Fibrosis via Inflammatory Signaling. Nat. Med. 2011, 18, 148–152.
    33. Netea, M.G.; Latz, E.; Mills, K.H.G.; O’Neill, L.A.J. Innate Immune Memory: A Paradigm Shift in Understanding Host Defense. Nat. Immunol. 2015, 16, 675–679.
    34. Croft, A.P.; Campos, J.; Jansen, K.; Turner, J.D.; Marshall, J.; Attar, M.; Savary, L.; Wehmeyer, C.; Naylor, A.J.; Kemble, S.; et al. Distinct Fibroblast Subsets Drive Inflammation and Damage in Arthritis. Nature 2019, 570, 246–251.
    35. Strle, K.; Locchead, R.; Pianta, A.; Crowley, J.T.; Arvikar, S. Fibroblast-like Synoviocytes Shape and Perpetuate the Inflammatory Immune Responses Associated with Antibiotic-Refractory Lyme Arthritis.—ACR Meeting Abstracts. Arthritis Rheumatol. 2015, 67, 9–10.
    36. Gilbane, A.J.; Denton, C.P.; Holmes, A.M. Scleroderma Pathogenesis: A Pivotal Role for Fibroblasts as Effector Cells. Arthritis Res. Ther. 2013, 15, 215.
    37. Berroth, A.; Kühnl, J.; Kurschat, N.; Schwarz, A.; Stäb, F.; Schwarz, T.; Wenck, H.; Fölster-Holst, R.; Neufang, G. Role of Fibroblasts in the Pathogenesis of Atopic Dermatitis. J. Allergy Clin. Immunol. 2013, 131, 1547–1554.
    38. Frevert, C.W.; Felgenhauer, J.; Wygrecka, M.; Nastase, M.V.; Schaefer, L. Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity. J. Histochem. Cytochem. Off. J. Histochem. Soc. 2018, 66, 213–227.
    39. Kyburz, D.; Brentano, F.; Schorr, O.; Michel, B.A.; Gay, R.E.; Gay, S. Toll-like Receptor Expression in Synovial Fibroblasts and Normal Skin Fibroblasts and Induction of Matrix Metallo-Proteinase Expression by Various Toll-like Receptor Ligands. Arthritis Res. Ther. 2005, 7, P119.
    40. Klein, K.; Frank-Bertoncelj, M.; Karouzakis, E.; Gay, R.E.; Kolling, C.; Ciurea, A.; Bostanci, N.; Belibasakis, G.N.; Lin, L.-L.; Distler, O.; et al. The Epigenetic Architecture at Gene Promoters Determines Cell Type-Specific LPS Tolerance. J. Autoimmun. 2017, 83, 122–133.
    41. Sohn, C.; Lee, A.; Qiao, Y.; Loupasakis, K.; Ivashkiv, L.B.; Kalliolias, G.D. Prolonged Tumor Necrosis Factor α Primes Fibroblast-like Synoviocytes in a Gene-Specific Manner by Altering Chromatin. Arthritis Rheumatol. 2015, 67, 86–95.
    42. Crowley, T.; O’Neil, J.D.; Adams, H.; Thomas, A.M.; Filer, A.; Buckley, C.D.; Clark, A.R. Priming in Response to Pro-Inflammatory Cytokines Is a Feature of Adult Synovial but Not Dermal Fibroblasts. Arthritis Res. Ther. 2017, 19, 35.
    43. Gangishetti, U.; Ramirez-Perez, S.; Jones, K.; Arif, A.; Drissi, H.; Bhattaram, P. Chronic Exposure to TNF Reprograms Cell Signaling Pathways in Fibroblast-like Synoviocytes by Establishing Long-Term Inflammatory Memory. bioRxiv 2020.
    44. Ghazarian, A.; Garner, W.L.; Ehrlich, H.P. Memory of Past Exposure to the Chemokine IL-8 Inhibits the Contraction of Fibroblast-Populated Collagen Lattices. Exp. Mol. Pathol. 2000, 69, 242–247.
    45. Nayar, S.; Campos, J.; Smith, C.G.; Iannizzotto, V.; Gardner, D.H.; Mourcin, F.; Roulois, D.; Turner, J.; Sylvestre, M.; Asam, S.; et al. Immunofibroblasts Are Pivotal Drivers of Tertiary Lymphoid Structure Formation and Local Pathology. Proc. Natl. Acad. Sci. USA 2019, 116, 13490–13497.
    46. O’Reilly, S.; Ciechomska, M.; Fullard, N.; Przyborski, S.; Van Laar, J.M. IL-13 Mediates Collagen Deposition via STAT6 and MicroRNA-135b: A Role for Epigenetics. Sci. Rep. 2016, 6, 1–13.
    47. Davidson-Moncada, J.; Papavasiliou, F.N.; Tam, W. MicroRNAs of the Immune System: Roles in Inflammation and Cancer. Ann. N. Y. Acad. Sci. 2010, 1183, 183–194.
    48. Saferding, V.; Puchner, A.; Goncalves-Alves, E.; Hofmann, M.; Bonelli, M.; Brunner, J.S.; Sahin, E.; Niederreiter, B.; Hayer, S.; Kiener, H.P.; et al. MicroRNA-146a Governs Fibroblast Activation and Joint Pathology in Arthritis. J. Autoimmun. 2017, 82, 74–84.
    49. Li, X.; Li, D.; Wikstrom, J.D.; Pivarcsi, A.; Sonkoly, E.; Ståhle, M.; Landén, N.X. MicroRNA-132 Promotes Fibroblast Migration via Regulating RAS P21 Protein Activator 1 in Skin Wound Healing. Sci. Rep. 2017, 7, 7797.
    50. Eissa, M.G.; Artlett, C.M. The MicroRNA MiR-155 Is Essential in Fibrosis. Non-Coding RNA 2019, 5, 23.
    51. Bustamante, M.F.; Oliveira, P.G.; Garcia-Carbonell, R.; Croft, A.P.; Smith, J.M.; Serrano, R.L.; Sanchez-Lopez, E.; Liu, X.; Kisseleva, T.; Hay, N.; et al. Hexokinase 2 as a Novel Selective Metabolic Target for Rheumatoid Arthritis. Ann. Rheum. Dis. 2018, 77, 1636–1643.
    52. Kowluru, R.A.; Zhong, Q.; Kanwar, M. Metabolic Memory and Diabetic Retinopathy: Role of Inflammatory Mediators in Retinal Pericytes. Exp. Eye Res. 2010, 90, 617–623.
    53. Villeneuve, L.M.; Reddy, M.A.; Lanting, L.L.; Wang, M.; Meng, L.; Natarajan, R. Epigenetic Histone H3 Lysine 9 Methylation in Metabolic Memory and Inflammatory Phenotype of Vascular Smooth Muscle Cells in Diabetes. Proc. Natl. Acad. Sci. USA 2008, 105, 9047–9052.
    54. Zhao, X.; Psarianos, P.; Ghoraie, L.S.; Yip, K.; Goldstein, D.; Gilbert, R.; Witterick, I.; Pang, H.; Hussain, A.; Lee, J.H.; et al. Metabolic Regulation of Dermal Fibroblasts Contributes to Skin Extracellular Matrix Homeostasis and Fibrosis. Nat. Metab. 2019, 1, 147–157.
    55. Bernard, K.; Logsdon, N.J.; Ravi, S.; Xie, N.; Persons, B.P.; Rangarajan, S.; Zmijewski, J.W.; Mitra, K.; Liu, G.; Darley-Usmar, V.M.; et al. Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation. J. Biol. Chem. 2015, 290, 25427–25438.
    56. Sang, L.; Coller, H.A.; Roberts, J.M. Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1. Science 2008, 321, 1095–1100.
    57. Coller, H.A.; Sang, L.; Roberts, J.M. A New Description of Cellular Quiescence. PLoS Biol. 2006, 4, e83.
    58. Lemons, J.M.S.; Feng, X.-J.; Bennett, B.D.; Legesse-Miller, A.; Johnson, E.L.; Raitman, I.; Pollina, E.A.; Rabitz, H.A.; Rabinowitz, J.D.; Coller, H.A. Quiescent Fibroblasts Exhibit High Metabolic Activity. PLoS Biol. 2010, 8, e1000514.
    59. Suh, E.J.; Remillard, M.Y.; Legesse-Miller, A.; Johnson, E.L.; Lemons, J.M.; Chapman, T.R.; Forman, J.J.; Kojima, M.; Silberman, E.S.; Coller, H.A. A MicroRNA Network Regulates Proliferative Timing and Extracellular Matrix Synthesis during Cellular Quiescence in Fibroblasts. Genome Biol. 2012, 13, R121.
    60. Li, M.; Riddle, S.; Zhang, H.; D’Alessandro, A.; Flockton, A.; Serkova, N.J.; Hansen, K.C.; Moldvan, R.; McKeon, B.A.; Frid, M.; et al. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1. Circulation 2016, 134, 1105–1121.
    61. Eckert, M.A.; Coscia, F.; Chryplewicz, A.; Chang, J.W.; Hernandez, K.M.; Pan, S.; Tienda, S.M.; Nahotko, D.A.; Li, G.; Blaženović, I.; et al. Proteomics Reveals NNMT as a Master Metabolic Regulator of Cancer-Associated Fibroblasts. Nature 2019, 569, 723–728.
    62. Plecitá-Hlavatá, L.; Tauber, J.; Li, M.; Zhang, H.; Flockton, A.R.; Pullamsetti, S.S.; Chelladurai, P.; D’Alessandro, A.; el Kasmi, K.C.; Ježek, P.; et al. Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension. Am. J. Respir. Cell Mol. Biol. 2016, 55, 47–57.
    63. Tian, L.; Wu, D.; Dasgupta, A.; Chen, K.H.; Mewburn, J.; Potus, F.; Lima, P.D.A.; Hong, Z.; Zhao, Y.Y.; Hindmarch, C.C.T.; et al. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis. Circ. Res. 2020, 126, 1723–1745.
    64. Watson, C.J.; Collier, P.; Tea, I.; Neary, R.; Watson, J.A.; Robinson, C.; Phelan, D.; Ledwidge, M.T.; McDonald, K.M.; McCann, A.; et al. Hypoxia-Induced Epigenetic Modifications Are Associated with Cardiac Tissue Fibrosis and the Development of a Myofibroblast-like Phenotype. Hum. Mol. Genet. 2014, 23, 2176–2188.
    65. Terranova, A. The Effects of Diabetes Mellitus on Wound Healing. Plast. Surg.Nurs. Off. J. Am. Soc. Plast. Reconstr. Surg. Nurses 1991, 11, 20–25.
    66. Caramori, M.L.; Kim, Y.; Natarajan, R.; Moore, J.H.; Rich, S.S.; Mychaleckyj, J.C.; Kuriyama, R.; Kirkpatrick, D.; Mauer, M. Differential Response to High Glucose in Skin Fibroblasts of Monozygotic Twins Discordant for Type 1 Diabetes. J. Clin. Endocrinol. Metab. 2015, 100, E883–E889.
    67. Park, L.K.; Maione, A.G.; Smith, A.; Gerami-Naini, B.; Iyer, L.K.; Mooney, D.J.; Veves, A.; Garlick, J.A. Genome-Wide DNA Methylation Analysis Identifies a Metabolic Memory Profile in Patient-Derived Diabetic Foot Ulcer Fibroblasts. Epigenetics 2014, 9, 1339–1349.
    68. Al-Rikabi, A.H.A.; Tobin, D.J.; Riches-Suman, K.; Thornton, M.J. Dermal Fibroblasts Cultured from Donors with Type 2 Diabetes Mellitus Retain an Epigenetic Memory Associated with Poor Wound Healing Responses. Sci. Rep. 2021, 11, 1474.
    69. Li, Q.; Qin, Z.; Nie, F.; Bi, H.; Zhao, R.; Pan, B.; Ma, J.; Xie, X. Metabolic Reprogramming in Keloid Fibroblasts: Aerobic Glycolysis and a Novel Therapeutic Strategy. Biochem. Biophys. Res. Commun. 2018, 496, 641–647.
    70. Salmond, R.J. MTOR Regulation of Glycolytic Metabolism in T Cells. Front. Cell Dev. Biol. 2018, 6, 122.
    71. Ma, G.; Samad, I.; Motz, K.; Yin, L.X.; Duvvuri, M.V.; Ding, D.; Namba, D.R.; Elisseeff, J.H.; Horton, M.R.; Hillel, A.T. Metabolic Variations in Normal and Fibrotic Human Laryngotracheal-Derived Fibroblasts: A Warburg-like Effect. Laryngoscope 2017, 127, E107–E113.
    72. Guido, C.; Whitaker-Menezes, D.; Capparelli, C.; Balliet, R.; Lin, Z.; Pestell, R.G.; Howell, A.; Aquila, S.; Andò, S.; Martinez-Outschoorn, U.; et al. Metabolic Reprogramming of Cancer-Associated Fibroblasts by TGF-β Drives Tumor Growth: Connecting TGF-β Signaling with “Warburg-like” Cancer Metabolism and L-Lactate Production. Cell Cycle (Georget. Tex.) 2012, 11, 3019–3035.
    73. Kvacskay, P.; Yao, N.; Schnotz, J.-H.; Scarpone, R.; de Albuquerque Carvalho, R.; Klika, K.D.; Merkt, W.; Tretter, T.; Lorenz, H.-M.; Tykocinski, L.-O. Increase of Aerobic Glycolysis Mediated by Activated T Helper Cells Drives Synovial Fibroblasts towards an Inflammatory Phenotype: New Targets for Therapy? Arthritis Res. Ther. 2021, 23, 56.
    74. Dabiri, G.; Tumbarello, D.A.; Turner, C.E.; van de Water, L. Hic-5 Promotes the Hypertrophic Scar Myofibroblast Phenotype by Regulating the TGF-Beta1 Autocrine Loop. J. Investig. Dermatol. 2008, 128, 2518–2525.